Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000700725 | SCV000829493 | likely benign | Long QT syndrome | 2023-09-04 | criteria provided, single submitter | clinical testing | |
New York Genome Center | RCV001291697 | SCV001480281 | uncertain significance | Timothy syndrome | 2019-10-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002343527 | SCV002646736 | uncertain significance | Cardiovascular phenotype | 2021-09-03 | criteria provided, single submitter | clinical testing | The p.S1742L variant (also known as c.5225C>T), located in coding exon 42 of the CACNA1C gene, results from a C to T substitution at nucleotide position 5225. The serine at codon 1742 is replaced by leucine, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |